Sorafenib (Nexavarl®) with metastasis sarcomatoid renal cell cancer after failure of a previous chemotherapy with Doxorubicin and Gemcitabine

被引：0
|
作者：
Staehler, M. [1 ]
Schoeppler, G. [1 ]
Haseke, N. [1 ]
Stadler, T. [1 ]
Karl, A. [1 ]
Stief, C. G. [1 ]
机构：
[1] Univ Munich, Urol Klin, Munich, Germany
来源：
ONKOLOGIE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [1] SORAFENIB AFTER COMBINATION THERAPY WITH GEMCITABINE PLUS DOXORUBICINE IN PATIENTS WITH SARCOMATOID RENAL CELL CARCINOMA: A PROSPECTIVE EVALUATION
    Staehler, M.
    Haseke, N.
    Roosen, A.
    Stadler, T.
    Bader, M.
    Siebels, M.
    Karl, A.
    Stief, C. G.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (07) : 287 - 291
  • [2] Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation
    M Staehler
    N Haseke
    A Roosen
    T Stadler
    M Bader
    M Siebels
    A Karl
    CG Stief
    European Journal of Medical Research, 15
  • [3] Combination of Gemcitabine and Doxorubicin in Rapidly Progressive Metastatic Renal Cell Carcinoma and/or Sarcomatoid Renal Cell Carcinoma
    Roubaud, G.
    Gross-Goupil, M.
    Wallerand, H.
    de Clermont, H.
    Dilhuydy, M. S.
    Ravaud, A.
    ONCOLOGY, 2011, 80 (3-4) : 214 - 218
  • [4] Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma
    S. Hoshi
    M. Satoh
    C. Ohyama
    M. Hiramatu
    R. Watanabe
    S. Hagisawa
    M. Endo
    Y. Arai
    International Journal of Clinical Oncology, 2003, 8 (2) : 0113 - 0117
  • [5] Combination of gemcitabine and doxorubicin in sarcomatoid and/or rapidly progressive metastatic renal cell carcinoma (MRCC)
    Roubaud, G.
    Dilhuydy, M. S.
    Pasticier, G.
    de Clermont, H.
    Smith, D.
    Rayaud, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 308 - 309
  • [6] A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802
    Haas, Naomi B.
    Lin, Xinyi
    Manola, Judith
    Pins, Michael
    Liu, Glenn
    McDermott, David
    Nanus, David
    Heath, Elisabeth
    Wilding, George
    Dutcher, Janice
    MEDICAL ONCOLOGY, 2012, 29 (02) : 761 - 767
  • [7] A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802
    Naomi B. Haas
    Xinyi Lin
    Judith Manola
    Michael Pins
    Glenn Liu
    David McDermott
    David Nanus
    Elisabeth Heath
    George Wilding
    Janice Dutcher
    Medical Oncology, 2012, 29 : 761 - 767
  • [8] Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma
    Numakura, Kazuyuki
    Tsuchiya, Norihiko
    Akihama, Susumu
    Inoue, Takamitsu
    Narita, Shintaro
    Huang, Mingguo
    Satoh, Shigeru
    Habuchi, Tomonori
    ONCOLOGY LETTERS, 2014, 8 (01) : 464 - 466
  • [9] Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer
    Grundbichler, Michael
    Mlineritsch, Brigitte
    Ressler, Sigrun
    Moik, Martin
    Kappacher, Andrea
    Rosenlechner, Sabine
    Greil, Richard
    ONCOLOGY, 2011, 80 (1-2) : 34 - 41
  • [10] Activity of gemcitabine (G) in sarcoma after failure of doxorubicin-based chemotherapy
    Merimsky, O
    Asna, N
    Flusser, G
    Kollender, Y
    Issakov, J
    Nirkin, A
    Meller, I
    Inbar, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S271 - S271
12345